Skye Bioscience, Inc.SKYENASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 27.63% |
| Q2 2025 | -58.74% |
| Q1 2025 | -13.92% |
| Q4 2024 | -150.02% |
| Q3 2024 | 50.67% |
| Q2 2024 | -57.44% |
| Q1 2024 | -13.57% |
| Q4 2023 | 82.28% |
| Q3 2023 | -701.73% |
| Q2 2023 | 39.79% |
| Q1 2023 | 47.76% |
| Q4 2022 | -216.30% |
| Q3 2022 | 8.54% |
| Q2 2022 | -12.35% |
| Q1 2022 | -21.11% |
| Q4 2021 | -37.70% |
| Q3 2021 | 9.84% |
| Q2 2021 | 6.32% |
| Q1 2021 | -43.83% |
| Q4 2020 | -15.84% |
| Q3 2020 | 8.70% |
| Q2 2020 | 39.35% |
| Q1 2020 | -148.26% |
| Q4 2019 | 198.40% |
| Q3 2019 | -131.00% |
| Q2 2019 | 207.66% |
| Q1 2019 | -137.45% |
| Q4 2018 | -196.85% |
| Q3 2018 | 21.26% |
| Q2 2018 | 67.59% |
| Q1 2018 | -1207.96% |
| Q4 2017 | -30.83% |
| Q3 2017 | 31.72% |
| Q2 2017 | 45.22% |
| Q1 2017 | -14.57% |
| Q4 2016 | -18.48% |
| Q3 2016 | -264.94% |
| Q2 2016 | 134.01% |
| Q1 2016 | -143.85% |
| Q4 2015 | 41.59% |